High dose rate endobronchial brachytherapy effectively palliates symptoms due to inoperable lung cancer

Abstract

Background: Intraluminal brachytherapy has become an established treatment for major airway occlusion by relapsed or persistent inoperable endobronchial tumors. The aim of this study was to compare the palliation improvement pre- and post-radiotherapy.